Wang, L., Wang, Y., Xie, Q., Xu, S., Yang, C., Liu, F., . . . Sun, L. (2024, December). Resveratrol liposomes reverse sorafenib resistance in renal cell carcinoma models by modulating PI3K-AKT-mTOR and VHL-HIF signaling pathways. International Journal of Pharmaceutics: X.
Chicago Style (17th ed.) CitationWang, Ligang, et al. "Resveratrol Liposomes Reverse Sorafenib Resistance in Renal Cell Carcinoma Models by Modulating PI3K-AKT-mTOR and VHL-HIF Signaling Pathways." International Journal of Pharmaceutics: X Dec. 2024.
MLA (9th ed.) CitationWang, Ligang, et al. "Resveratrol Liposomes Reverse Sorafenib Resistance in Renal Cell Carcinoma Models by Modulating PI3K-AKT-mTOR and VHL-HIF Signaling Pathways." International Journal of Pharmaceutics: X, Dec. 2024.
Warning: These citations may not always be 100% accurate.